- Home
- / Wuhan EasyDiagnosis Biomedicine
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Wuhan EasyDiagnosis Biomedicine financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥18.6
2024-10-29
Market Capitalization
¥4.2 B
2024-10-29
Revenue
¥243.9 M
FY, 2025
CreditSafe Score
?
Score changed on Jul 25, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 175.0M | 179.9M | 953.6M | 2.8B | 10.5B | 747.2M | 348.5M | 243.9M |
| Cost of goods sold | 40.4M | 46.5M | 209.0M | 707.0M | 3.5B | 342.7M | 161.4M | 169.2M |
| Gross profit | 134.6M | 133.4M | 744.6M | 2.1B | 7.0B | 404.6M | 187.1M | 92.0M |
| Gross profit margin, % | 74.1% | 78.1% | 74.9% | 66.7% | 54.1% | 53.7% | 37.7% | |
| Operating expense total | 64.9M | 84.6M | 170.0M | 379.3M | 930.9M | 296.9M | 220.8M | 178.8M |
| Depreciation and amortization | 13.2M | 16.8M | 17.2M | 21.3M | 185.9M | 104.3M | 91.9M | 55.0M |
| EBITDA | 69.7M | 48.7M | 568.1M | 1.7B | 6.0B | 101.0M | (34.9M) | (83.3M) |
| EBITDA margin, % | 27.1% | 59.6% | 61.2% | 57.7% | 13.5% | -10.0% | -34.2% | |
| EBIT | 66.5M | 38.9M | 552.8M | 1.7B | 5.0B | 24.5M | (110.8M) | (169.7M) |
| EBIT margin, % | 21.6% | 58.0% | 59.9% | 47.8% | 3.3% | -31.8% | -69.6% | |
| Interest income | 1.8M | 3.1M | 4.9M | 11.7M | 17.7M | 4.4M | 10.4M | 4.5M |
| Interest expense | 369.0K | 654.0K | 2.1M | 3.4M | 10.5M | 1.3M | 459.0K | |
| Pre tax profit | 70.8M | 46.6M | 556.7M | 1.7B | 5.1B | 139.9M | 32.4M | (63.8M) |
| Income tax expense | 8.4M | 4.0M | 81.1M | 247.9M | 695.9M | 70.7M | 5.9M | 11.3M |
| Net Income | 62.5M | 42.5M | 475.6M | 1.4B | 4.4B | 69.2M | 26.6M | (75.1M) |